TM
HAE icon

Torren Management’s Haemonetics HAE Stock Holding History

Torren Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$750 Hold
10
– – ﹤0.01% 787
2026
Q1 		$564 Sell
10
-18
-64% -$1.17K ﹤0.01% 861
2025
Q4 		$2.24K Buy
+28
New +$1.88K ﹤0.01% 1043

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

Torren Management's HAE Position: Q2 2026 in Review

Torren Management held its Haemonetics (HAE) position steady in Q2 2026 at 10 shares worth $750. The position accounts for ﹤0.01% of the portfolio, ranked #787.

Torren Management first reported a position in HAE in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.24K in Q4 2025. 136 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Torren Management held 10 shares of Haemonetics worth $750 as of Q2 2026.
  • Torren Management left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of Torren Management's portfolio in Q2 2026, its #787 holding.
  • Torren Management first reported a position in Haemonetics in Q4 2025 and has held it in 3 quarters since.
  • Torren Management's Haemonetics position peaked at $2.24K in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.